How to Make an Alzheimer’s Diagnosis in Primary Care: A Podcast with Nathaniel Chin
GeriPal
FEBRUARY 6, 2025
We now have biomarkers that can reasonably approximate the degree of amyloid build-up in the brain with a simple blood test. We have two new FDA-approved medications that reduce that amyloid buildup and modestly slow down the progression of the disease. How should we screen for cognitive impairment? Great to be back.
Let's personalize your content